Nathan Hardy

Insider Reports History

Location
Seattle, WA
Signature
/s/ Julie Shah, Attorney-in-Fact for Nathan Hardy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nathan Hardy:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sana Biotechnology, Inc. EVP, Chief Financial Officer Restricted Stock Units 67,083 $368,957 $5.50 07 Mar 2024 Direct
Sana Biotechnology, Inc. EVP, Chief Financial Officer Stock Option (Right to Buy) 301,875 07 Mar 2024 Direct

Insider Reports Filed by Nathan Hardy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SANA Sana Biotechnology, Inc. 07 Mar 2024 2 $0 4 EVP, Chief Financial Officer 08 Mar 2024, 16:16
SANA Sana Biotechnology, Inc. 02 Nov 2023 1 $0 4 EVP, Chief Financial Officer 03 Nov 2023, 16:07
SANA Sana Biotechnology, Inc. 02 Mar 2023 1 $0 4 EVP, Chief Financial Officer 03 Mar 2023, 15:34
SANA Sana Biotechnology, Inc. 03 Mar 2022 1 $0 4 EVP, Chief Financial Officer 08 Mar 2022, 08:03